AstraZeneca Pharma India Ltd announced its unaudited financial results for the quarter ending June 30, 2025, showing a net profit of Rs. 558.3 million compared to a net loss of Rs. 117.9 million in the same quarter last year. The publication also stated that operations at the manufacturing site have ceased and decommissioning has started as of this quarter.